Precision BioSciences (DTIL) Earnings Date, Estimates & Call Transcripts $4.52 +0.07 (+1.57%) Closing price 04:00 PM EasternExtended Trading$4.53 +0.01 (+0.20%) As of 05:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Precision BioSciences Earnings Summary Precision BioSciences posted Q1 2025 earnings on May 15, 2025, reporting an EPS of -$2.21, which missed analysts' consensus estimates of -$0.43 by $1.78. Quarterly revenue was reported to be $0.03 million, below analysts' expectations of $5 million. With a trailing EPS of -$2.01, Precision BioSciences' earnings are expected to grow next year, from ($1.23) to ($1.05) per share. Upcoming Q2 Earnings DateJul. 30Before Market OpensEstimatedConsensus EPS (May. 15) -$0.43 Actual EPS (May. 15) -$2.21 Missed By -$1.78 Actual Revenue (May. 15) $0.03MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)DTIL Upcoming EarningsPrecision BioSciences' Q2 2025 earnings is scheduled for Wednesday, July 30, 2025, with a conference call scheduled on Thursday, July 31, 2025 at 7:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Precision BioSciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Precision BioSciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataDTIL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DTIL Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Precision BioSciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.38-$0.38-$0.38Q2 20251-$0.09-$0.09-$0.09Q3 20251-$0.38-$0.38-$0.38Q4 20251-$0.26-$0.26-$0.26 Precision BioSciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/30/2025(Estimated)--------5/15/2025Q1 2025-$0.43-$2.21 -$1.78-$2.21$5.00M$0.03M3/26/2025Q4 2024-$2.09-$3.20 -$1.11-$2.22$4.28M$3.47M8/1/2024Q2 2024 -$0.77$3.46+$4.23$2.25$8.50M$49.90M5/13/2024Q1 2024 -$0.45-$0.35+$0.10-$2.40$9.35M$17.58M3/27/2024Q4 2023$3.00-$3.35 -$6.35-$2.64$28.50M$7.04M11/7/2023Q3 2023 -$5.70-$3.00+$2.70-$0.13$7.50M$13.12M8/4/2023Q2 2023-$6.90-$3.00+$3.90-$0.10$6.58M$19.79M Precision BioSciences Earnings - Frequently Asked Questions When is Precision BioSciences' earnings date? Precision BioSciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 30th, 2025 based off last year's report dates. Learn more on DTIL's earnings history. Did Precision BioSciences beat their earnings estimates last quarter? In the previous quarter, Precision BioSciences (NASDAQ:DTIL) missed the analysts' consensus estimate of ($0.43) by $1.78 with a reported earnings per share (EPS) of ($2.21). Learn more on analysts' earnings estimate vs. DTIL's actual earnings. How much revenue does Precision BioSciences generate each year? Precision BioSciences (NASDAQ:DTIL) has a recorded annual revenue of $51.14 million. How much profit does Precision BioSciences generate each year? Precision BioSciences (NASDAQ:DTIL) has a recorded net income of $7.17 million. DTIL has generated -$2.01 earnings per share over the last four quarters. What is Precision BioSciences' EPS forecast for next year? Precision BioSciences' earnings are expected to grow from ($1.23) per share to ($1.05) per share in the next year. More Earnings Resources from MarketBeat Related Companies Organigram Global Earnings Date ProKidney Earnings Date Alumis Earnings Date Eledon Pharmaceuticals Earnings Date Cybin Earnings Date Instil Bio Earnings Date Puma Biotechnology Earnings Date Voyager Therapeutics Earnings Date I-Mab Earnings Date Lifevantage Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles 3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings ReportSmith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still Strong This page (NASDAQ:DTIL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersBank of America Says Gold Could Hit $4,000. Here How to Get Paid“I’ve always hated gold. It doesn’t pay dividends… it just sits there.” That’s what one income strategist b...Investors Alley | SponsoredRevolutionary AI Tech Targets Early Diabetic Blindness Detection FDA Trial UnderwayTiny Stock, Massive Potential— this company’s AI platform is a game changer for healthcare!Interactive Offers | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precision BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precision BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DTIL Stock Alerts